Linezolid resistance in Mycobacterium tuberculosis isolates at a tertiary care centre in Mumbai, India

BACKGROUND & OBJECTIVES: Linezolid (LZD) is increasingly being used in tuberculosis (TB) treatment. However, LZD resistance has already been reported, which is highly alarming, given its critical therapeutic role. This study was aimed to phenotypically and genotypically assess LZD resistance in...

Descripción completa

Detalles Bibliográficos
Autores principales: Nambiar, Remya, Tornheim, Jeffrey A., Diricks, Margo, Bruyne, Katrien De, Sadani, Meeta, Shetty, Anjali, Rodrigues, Camilla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715694/
https://www.ncbi.nlm.nih.gov/pubmed/34782533
http://dx.doi.org/10.4103/ijmr.IJMR_1168_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715694/
https://www.ncbi.nlm.nih.gov/pubmed/34782533
http://dx.doi.org/10.4103/ijmr.IJMR_1168_19

Ejemplares similares